Sunflower Pharmaceuticals Group Co Ltd (002737) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.028x

Based on the latest financial reports, Sunflower Pharmaceuticals Group Co Ltd (002737) has a cash flow conversion efficiency ratio of -0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-117.97 Million ≈ $-17.26 Million USD) by net assets (CN¥4.23 Billion ≈ $619.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sunflower Pharmaceuticals Group Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Sunflower Pharmaceuticals Group Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Sunflower Pharmaceuticals Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Sunflower Pharmaceuticals Group Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Sunflower Pharmaceuticals Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sunflower Pharmaceuticals Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Success Electronics Ltd SHE:002289	0.049x
Northwest Pipe Company NASDAQ:NWPX	0.072x
ISC Co. Ltd KQ:095340	0.030x
Goldsun Building Materials Co Ltd TW:2504	0.053x
Procter & Gamble Health Limited NSE:PGHL	0.278x
Hunan Friendship&Apollo Commercial Co Ltd SHE:002277	0.016x
Guangdong Golden Dragon Development Inc SHE:000712	0.203x
Shanghai Chlor-Alkali Chemical Co Ltd A SHG:600618	0.012x

Annual Cash Flow Conversion Efficiency for Sunflower Pharmaceuticals Group Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Sunflower Pharmaceuticals Group Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Sunflower Pharmaceuticals Group Co Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.99 Billion ≈ $583.96 Million	CN¥574.97 Million ≈ $84.14 Million	0.144x	+315.08%
2024-12-31	CN¥4.59 Billion ≈ $671.66 Million	CN¥-307.48 Million ≈ $-44.99 Million	-0.067x	-136.31%
2023-12-31	CN¥5.00 Billion ≈ $732.34 Million	CN¥923.30 Million ≈ $135.11 Million	0.184x	-58.45%
2022-12-31	CN¥4.44 Billion ≈ $649.53 Million	CN¥1.97 Billion ≈ $288.39 Million	0.444x	+101.93%
2021-12-31	CN¥3.94 Billion ≈ $575.83 Million	CN¥865.23 Million ≈ $126.61 Million	0.220x	-36.27%
2020-12-31	CN¥3.39 Billion ≈ $496.17 Million	CN¥1.17 Billion ≈ $171.19 Million	0.345x	+20.58%
2019-12-31	CN¥3.43 Billion ≈ $501.87 Million	CN¥981.33 Million ≈ $143.60 Million	0.286x	+13.53%
2018-12-31	CN¥3.44 Billion ≈ $502.93 Million	CN¥866.21 Million ≈ $126.75 Million	0.252x	+42.60%
2017-12-31	CN¥3.16 Billion ≈ $462.64 Million	CN¥558.77 Million ≈ $81.77 Million	0.177x	+45.25%
2016-12-31	CN¥2.80 Billion ≈ $410.38 Million	CN¥341.23 Million ≈ $49.93 Million	0.122x	+152.41%
2015-12-31	CN¥2.61 Billion ≈ $381.99 Million	CN¥125.84 Million ≈ $18.41 Million	0.048x	-72.75%
2014-12-31	CN¥2.28 Billion ≈ $333.59 Million	CN¥403.23 Million ≈ $59.00 Million	0.177x	-47.60%
2013-12-31	CN¥869.02 Million ≈ $127.17 Million	CN¥293.34 Million ≈ $42.93 Million	0.338x	-21.79%
2012-12-31	CN¥758.39 Million ≈ $110.98 Million	CN¥327.31 Million ≈ $47.90 Million	0.432x	-8.95%
2011-12-31	CN¥543.47 Million ≈ $79.53 Million	CN¥257.60 Million ≈ $37.70 Million	0.474x	--

About Sunflower Pharmaceuticals Group Co Ltd

SHE:002737 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.17 Billion

CN¥7.98 Billion CNY

Market Cap Rank

#8153 Global

#1849 in China

Share Price

CN¥13.66

Change (1 day)

+1.04%

52-Week Range

CN¥11.21 - CN¥16.38

All Time High

CN¥28.79